| Product Code: ETC7783669 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Kazakhstan insulin biosimilars market, the import trend experienced a notable decline from 2023 to 2024, with a growth rate of -26.57%. The compound annual growth rate (CAGR) for the period 2020-2024 stood at -16.15%. This decline in imports could be attributed to shifting demand dynamics or changes in trade policies impacting market stability.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kazakhstan Insulin Biosimilars Market Overview |
3.1 Kazakhstan Country Macro Economic Indicators |
3.2 Kazakhstan Insulin Biosimilars Market Revenues & Volume, 2021 & 2031F |
3.3 Kazakhstan Insulin Biosimilars Market - Industry Life Cycle |
3.4 Kazakhstan Insulin Biosimilars Market - Porter's Five Forces |
3.5 Kazakhstan Insulin Biosimilars Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Kazakhstan Insulin Biosimilars Market Revenues & Volume Share, By Indicative, 2021 & 2031F |
3.7 Kazakhstan Insulin Biosimilars Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Kazakhstan Insulin Biosimilars Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Kazakhstan Insulin Biosimilars Market Trends |
6 Kazakhstan Insulin Biosimilars Market, By Types |
6.1 Kazakhstan Insulin Biosimilars Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Kazakhstan Insulin Biosimilars Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Kazakhstan Insulin Biosimilars Market Revenues & Volume, By Rapid-acting biosimilar, 2021- 2031F |
6.1.4 Kazakhstan Insulin Biosimilars Market Revenues & Volume, By Long-acting biosimilar, 2021- 2031F |
6.1.5 Kazakhstan Insulin Biosimilars Market Revenues & Volume, By Premixed biosimilar, 2021- 2031F |
6.2 Kazakhstan Insulin Biosimilars Market, By Indicative |
6.2.1 Overview and Analysis |
6.2.2 Kazakhstan Insulin Biosimilars Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.2.3 Kazakhstan Insulin Biosimilars Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.3 Kazakhstan Insulin Biosimilars Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Kazakhstan Insulin Biosimilars Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Kazakhstan Insulin Biosimilars Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 Kazakhstan Insulin Biosimilars Market Revenues & Volume, By Others, 2021- 2031F |
7 Kazakhstan Insulin Biosimilars Market Import-Export Trade Statistics |
7.1 Kazakhstan Insulin Biosimilars Market Export to Major Countries |
7.2 Kazakhstan Insulin Biosimilars Market Imports from Major Countries |
8 Kazakhstan Insulin Biosimilars Market Key Performance Indicators |
9 Kazakhstan Insulin Biosimilars Market - Opportunity Assessment |
9.1 Kazakhstan Insulin Biosimilars Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Kazakhstan Insulin Biosimilars Market Opportunity Assessment, By Indicative, 2021 & 2031F |
9.3 Kazakhstan Insulin Biosimilars Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Kazakhstan Insulin Biosimilars Market - Competitive Landscape |
10.1 Kazakhstan Insulin Biosimilars Market Revenue Share, By Companies, 2024 |
10.2 Kazakhstan Insulin Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |